HEADER HYDROLASE 10-DEC-21 7QGW TITLE SULFONATED CALPEPTIN IS A PROMISING DRUG CANDIDATE AGAINST SARS-COV-2 TITLE 2 INFECTIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN L2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CATHEPSIN U,CATHEPSIN V; COMPND 5 EC: 3.4.22.43; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSV, CATL2, CTSL2, CTSU, UNQ268/PRO305; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PHAFFII GS115; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 644223 KEYWDS CATHEPSIN, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.LOBODA,K.KARNICAR,N.LINDIC,A.USENIK,J.LIESKE,A.MEENTS,S.GUENTHER, AUTHOR 2 P.Y.A.REINKE,S.FALKE,W.EWERT,D.TURK REVDAT 3 31-JAN-24 7QGW 1 REMARK REVDAT 2 01-NOV-23 7QGW 1 JRNL REVDAT 1 21-DEC-22 7QGW 0 JRNL AUTH P.Y.A.REINKE,E.E.DE SOUZA,S.GUNTHER,S.FALKE,J.LIESKE, JRNL AUTH 2 W.EWERT,J.LOBODA,A.HERRMANN,A.RAHMANI MASHHOUR,K.KARNICAR, JRNL AUTH 3 A.USENIK,N.LINDIC,A.SEKIRNIK,V.F.BOTOSSO,G.M.M.SANTELLI, JRNL AUTH 4 J.KAPRONEZAI,M.V.DE ARAUJO,T.T.SILVA-PEREIRA,A.F.S.FILHO, JRNL AUTH 5 M.S.TAVARES,L.FLOREZ-ALVAREZ,D.B.L.DE OLIVEIRA,E.L.DURIGON, JRNL AUTH 6 P.R.GIARETTA,M.B.HEINEMANN,M.HAUSER,B.SEYCHELL,H.BOHLER, JRNL AUTH 7 W.RUT,M.DRAG,T.BECK,R.COX,H.N.CHAPMAN,C.BETZEL,W.BREHM, JRNL AUTH 8 W.HINRICHS,G.EBERT,S.L.LATHAM,A.M.S.GUIMARAES,D.TURK, JRNL AUTH 9 C.WRENGER,A.MEENTS JRNL TITL CALPEPTIN IS A POTENT CATHEPSIN INHIBITOR AND DRUG CANDIDATE JRNL TITL 2 FOR SARS-COV-2 INFECTIONS. JRNL REF COMMUN BIOL V. 6 1058 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 37853179 JRNL DOI 10.1038/S42003-023-05317-9 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : MAIN 2021 REMARK 3 AUTHORS : TURK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 138983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RKICK REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 100.00 REMARK 3 FREE R VALUE TEST SET COUNT : 13898 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 1.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6775 REMARK 3 BIN R VALUE (WORKING SET) : 0.2454 REMARK 3 BIN FREE R VALUE : 0.2775 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 100.0 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 6775 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3380 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 0.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FREE KICK ML TARGET FUNCTION USES ALL REMARK 3 DATA FOR ESTIMATING PHASE ERRORS REMARK 4 REMARK 4 7QGW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292119414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 11.2C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 139006 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 23.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1FH0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 77 % MPD, 23 % OF 60 MM TRIS, PH 8, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.48000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.12000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 95.22000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.12000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 31.74000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.12000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.12000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 95.22000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.12000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.12000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 31.74000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 63.48000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -111.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 160 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 673 O HOH A 717 1.45 REMARK 500 O HOH B 857 O HOH B 896 1.75 REMARK 500 O HOH A 615 O HOH A 717 1.87 REMARK 500 O HOH A 497 O HOH A 658 1.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 20 -145.37 54.27 REMARK 500 LYS A 148 -36.73 -134.20 REMARK 500 CYS A 210 16.59 57.24 REMARK 500 LYS B 242 -143.07 55.13 REMARK 500 CYS B 432 16.28 59.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 733 DISTANCE = 6.09 ANGSTROMS DBREF 7QGW A 1 221 UNP O60911 CATL2_HUMAN 114 334 DBREF 7QGW B 223 443 UNP O60911 CATL2_HUMAN 114 334 SEQADV 7QGW GLN A 108 UNP O60911 ASN 221 ENGINEERED MUTATION SEQADV 7QGW GLN A 179 UNP O60911 ASN 292 ENGINEERED MUTATION SEQADV 7QGW GLN B 330 UNP O60911 ASN 221 ENGINEERED MUTATION SEQADV 7QGW GLN B 401 UNP O60911 ASN 292 ENGINEERED MUTATION SEQRES 1 A 221 LEU PRO LYS SER VAL ASP TRP ARG LYS LYS GLY TYR VAL SEQRES 2 A 221 THR PRO VAL LYS ASN GLN LYS GLN CYS GLY SER CYS TRP SEQRES 3 A 221 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 A 221 ARG LYS THR GLY LYS LEU VAL SER LEU SER GLU GLN ASN SEQRES 5 A 221 LEU VAL ASP CYS SER ARG PRO GLN GLY ASN GLN GLY CYS SEQRES 6 A 221 ASN GLY GLY PHE MET ALA ARG ALA PHE GLN TYR VAL LYS SEQRES 7 A 221 GLU ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 A 221 VAL ALA VAL ASP GLU ILE CYS LYS TYR ARG PRO GLU ASN SEQRES 9 A 221 SER VAL ALA GLN ASP THR GLY PHE THR VAL VAL ALA PRO SEQRES 10 A 221 GLY LYS GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL SEQRES 11 A 221 GLY PRO ILE SER VAL ALA MET ASP ALA GLY HIS SER SER SEQRES 12 A 221 PHE GLN PHE TYR LYS SER GLY ILE TYR PHE GLU PRO ASP SEQRES 13 A 221 CYS SER SER LYS ASN LEU ASP HIS GLY VAL LEU VAL VAL SEQRES 14 A 221 GLY TYR GLY PHE GLU GLY ALA ASN SER GLN ASN SER LYS SEQRES 15 A 221 TYR TRP LEU VAL LYS ASN SER TRP GLY PRO GLU TRP GLY SEQRES 16 A 221 SER ASN GLY TYR VAL LYS ILE ALA LYS ASP LYS ASN ASN SEQRES 17 A 221 HIS CYS GLY ILE ALA THR ALA ALA SER TYR PRO ASN VAL SEQRES 1 B 221 LEU PRO LYS SER VAL ASP TRP ARG LYS LYS GLY TYR VAL SEQRES 2 B 221 THR PRO VAL LYS ASN GLN LYS GLN CYS GLY SER CYS TRP SEQRES 3 B 221 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 B 221 ARG LYS THR GLY LYS LEU VAL SER LEU SER GLU GLN ASN SEQRES 5 B 221 LEU VAL ASP CYS SER ARG PRO GLN GLY ASN GLN GLY CYS SEQRES 6 B 221 ASN GLY GLY PHE MET ALA ARG ALA PHE GLN TYR VAL LYS SEQRES 7 B 221 GLU ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 B 221 VAL ALA VAL ASP GLU ILE CYS LYS TYR ARG PRO GLU ASN SEQRES 9 B 221 SER VAL ALA GLN ASP THR GLY PHE THR VAL VAL ALA PRO SEQRES 10 B 221 GLY LYS GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL SEQRES 11 B 221 GLY PRO ILE SER VAL ALA MET ASP ALA GLY HIS SER SER SEQRES 12 B 221 PHE GLN PHE TYR LYS SER GLY ILE TYR PHE GLU PRO ASP SEQRES 13 B 221 CYS SER SER LYS ASN LEU ASP HIS GLY VAL LEU VAL VAL SEQRES 14 B 221 GLY TYR GLY PHE GLU GLY ALA ASN SER GLN ASN SER LYS SEQRES 15 B 221 TYR TRP LEU VAL LYS ASN SER TRP GLY PRO GLU TRP GLY SEQRES 16 B 221 SER ASN GLY TYR VAL LYS ILE ALA LYS ASP LYS ASN ASN SEQRES 17 B 221 HIS CYS GLY ILE ALA THR ALA ALA SER TYR PRO ASN VAL HET CL A 301 1 HET CL A 302 1 HET CL A 303 1 HET MPD A 304 8 HET GOL A 305 6 HET CL A 306 1 HET GOL A 307 6 HET MPD A 308 8 HET RN2 A 309 57 HET MPD B 501 8 HET CL B 502 1 HET GOL B 503 6 HET MPD B 504 8 HET GOL B 505 6 HET GOL B 506 6 HET CL B 507 1 HET MPD B 508 8 HET GOL B 509 6 HET RN2 B 510 57 HETNAM CL CHLORIDE ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM GOL GLYCEROL HETNAM RN2 CALPEPTIN HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 CL 6(CL 1-) FORMUL 6 MPD 5(C6 H14 O2) FORMUL 7 GOL 6(C3 H8 O3) FORMUL 11 RN2 2(C20 H32 N2 O4) FORMUL 22 HOH *680(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 SER A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 GLN A 63 GLY A 67 5 5 HELIX 5 AA5 PHE A 69 GLY A 81 1 13 HELIX 6 AA6 ARG A 101 GLU A 103 5 3 HELIX 7 AA7 LYS A 119 VAL A 130 1 12 HELIX 8 AA8 HIS A 141 PHE A 146 1 6 HELIX 9 AA9 ASN A 208 ILE A 212 5 5 HELIX 10 AB1 ARG B 230 GLY B 233 5 4 HELIX 11 AB2 SER B 246 GLY B 265 1 20 HELIX 12 AB3 SER B 271 SER B 279 1 9 HELIX 13 AB4 ARG B 280 GLY B 283 5 4 HELIX 14 AB5 GLN B 285 GLY B 289 5 5 HELIX 15 AB6 PHE B 291 GLY B 303 1 13 HELIX 16 AB7 ARG B 323 GLU B 325 5 3 HELIX 17 AB8 LYS B 341 VAL B 352 1 12 HELIX 18 AB9 HIS B 363 PHE B 368 1 6 HELIX 19 AC1 ASN B 430 ILE B 434 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 HIS A 164 GLY A 172 -1 O TYR A 171 N VAL A 5 SHEET 3 AA1 3 ILE A 133 MET A 137 -1 N ILE A 133 O VAL A 168 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 164 GLY A 172 -1 O TYR A 171 N VAL A 5 SHEET 3 AA2 5 TYR A 183 LYS A 187 -1 O LYS A 187 N LEU A 167 SHEET 4 AA2 5 TYR A 199 ALA A 203 -1 O ILE A 202 N TRP A 184 SHEET 5 AA2 5 ILE A 151 TYR A 152 1 N TYR A 152 O LYS A 201 SHEET 1 AA3 2 LEU A 83 ASP A 84 0 SHEET 2 AA3 2 SER A 105 ALA A 107 -1 O VAL A 106 N LEU A 83 SHEET 1 AA4 2 PHE A 112 VAL A 114 0 SHEET 2 AA4 2 SER A 217 PRO A 219 -1 O TYR A 218 N THR A 113 SHEET 1 AA5 3 VAL B 227 ASP B 228 0 SHEET 2 AA5 3 HIS B 386 PHE B 395 -1 O TYR B 393 N VAL B 227 SHEET 3 AA5 3 ILE B 355 MET B 359 -1 N ILE B 355 O VAL B 390 SHEET 1 AA6 5 VAL B 227 ASP B 228 0 SHEET 2 AA6 5 HIS B 386 PHE B 395 -1 O TYR B 393 N VAL B 227 SHEET 3 AA6 5 LYS B 404 LYS B 409 -1 O LYS B 409 N LEU B 389 SHEET 4 AA6 5 TYR B 421 ALA B 425 -1 O ILE B 424 N TRP B 406 SHEET 5 AA6 5 ILE B 373 TYR B 374 1 N TYR B 374 O LYS B 423 SHEET 1 AA7 2 LEU B 305 ASP B 306 0 SHEET 2 AA7 2 SER B 327 ALA B 329 -1 O VAL B 328 N LEU B 305 SHEET 1 AA8 2 PHE B 334 VAL B 336 0 SHEET 2 AA8 2 SER B 439 PRO B 441 -1 O TYR B 440 N THR B 335 SSBOND 1 CYS A 22 CYS A 65 1555 1555 2.04 SSBOND 2 CYS A 56 CYS A 98 1555 1555 2.03 SSBOND 3 CYS A 157 CYS A 210 1555 1555 2.04 SSBOND 4 CYS B 244 CYS B 287 1555 1555 2.04 SSBOND 5 CYS B 278 CYS B 320 1555 1555 2.04 SSBOND 6 CYS B 379 CYS B 432 1555 1555 2.03 LINK SG CYS A 25 C25 RN2 A 309 1555 1555 1.85 LINK SG CYS B 247 C25 RN2 B 510 1555 1555 1.92 CRYST1 94.240 94.240 126.960 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010611 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007876 0.00000